Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Lleida.net highlights digital identity and trust services at Money20/20 Europe fintech event

Market News
04 Jun 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Lleida.net showcased its digital identity, digital wallet, and trust services at the Money20/20 Europe event in Amsterdam to strengthen its position in the fintech ecosystem. The company emphasized innovations like digital certificate validation and centralized electronic signatures compliant with eIDAS regulations, which support secure and efficient digital processes for businesses and public administrations. Recently, Lleida.net's registered electronic mail was legally recognized by Spanish courts as valid proof for procedural compliance, enhancing its credibility. Founded in 1995, Lleida.net is a leading European provider of digital trust services, holding over 300 patents and listed on multiple European stock exchanges.

More News

Hamanasi Resort in Belize named #1 hotel in Central America and #15 worldwide by Tripadvisor in 2026.

Hamanasi Resort in Belize named #1 hotel in Central America and #15 worldwide by Tripadvisor in 2026.

Hamanasi Adventure & Dive Resort in Belize was ranked the #1 hotel in Central America and #15 globally in the 2026 Tripadvisor Travelers’ Choice Best of the Best Awards. This prestigious recognition is based on exceptional guest reviews and highlight...

Others
Neutral
58 minutes ago
US government buys 10% stake in mining firms, signaling a new strategic investment trend.

US government buys 10% stake in mining firms, signaling a new strategic investment trend.

In early 2026, the US government began acquiring stakes in American mining companies, including a 10% share in USA Rare Earth to support critical mineral projects. This move follows similar investments in Lithium Americas and Trilogy Metals, which sa...

Market News
Bullish
1 hour ago
FDA approves Sanofi's Tzield as first disease-modifying therapy for stage 3 type 1 diabetes in children.

FDA approves Sanofi's Tzield as first disease-modifying therapy for stage 3 type 1 diabetes in children.

The FDA has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). This is the first disease-modifying therapy aimed at delaying the decline of insulin produc...

Market News
Bullish
2 hours ago
FDA approves Sanofi's Tzield as first disease-modifying therapy for newly diagnosed stage 3 type 1 diabetes in children.

FDA approves Sanofi's Tzield as first disease-modifying therapy for newly diagnosed stage 3 type 1 diabetes in children.

The FDA granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes (T1D). Tzield slows the decline of the body's insulin production by targeting the autoimmune process c...

Market News
Bullish
2 hours ago
Heartland Express declares $0.02 quarterly dividend, continuing 92 quarters of payouts.

Heartland Express declares $0.02 quarterly dividend, continuing 92 quarters of payouts.

Heartland Express, Inc. announced a regular quarterly cash dividend of $0.02 per share, payable on July 6, 2026, to shareholders of record as of June 23, 2026. This marks the company's 92nd consecutive quarterly dividend, with a total payout of $564....

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App